Teva considers sale of its active ingredients unit: Bloomberg

Shares of Teva are fluctuating after a report from Bloomberg that the company is considering a sale of its active ingredients business. Yahoo Finance Healthcare Reporter Anjalee Khemlani breaks down the story.